Orkin’s parent, Rollins, has 100 straight quarters of revenue growth; Q3 net income fell 3.4%.

Rollins, parent of Orkin, reported 100 straight quarters of revenue growth. Q3 2026 revenue rose 6.2% YoY to $1.1B, but net income fell 3.4% to $157.9M. Operating income declined 1.0% to $222.9M. Management cited customer acquisition challenges but remains confident in long-term growth. Operating cash flow increased 26.4% to $241.9M.

Original reporting
Published Oct 21, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$ROL
Relevance
8/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

Med
01

Why it matters

Quarterly earnings show mixed results: revenue growth but margin compression and lower net income.

02

Market read

First‑time earnings release with material financial figures for a large‑cap U.S. company.

03

What to watch

Strong cash flow and continued share repurchases could support the stock despite earnings miss.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Rollins Inc. (ticker RLI) is the parent of pest‑control firm Orkin, known for consistent revenue growth.

Market effects

Pest‑control sector may see broader scrutiny of margin trends.

U.S. consumer‑services stocks could face modest pressure.

Limited to U.S. markets; no direct global ripple.

Counterpoint

The 100‑quarter revenue streak suggests long‑term resilience; the dip may be temporary.

Key entities

  • Rollins Inc.

    Parent company of Orkin, provides pest‑control services.

Related articles

$ROLMed

Why is Rollins stock climbing today?

Rollins stock rose 1.6% in pre-market trading after Citi upgraded it to Buy with a $49 price target, up from $32. Wells Fargo also raised its target to $30. Institutional and insider buying added support. The broader market was up, with the S&P 500 gaining 0.6%. Rollins is still below its 52-week high of $66.14.

$ROLMed

Canaccord lowers Rollins stock price target on weak Q3 results

Canaccord reduced its price target for Rollins Inc. (NYSE: ROL) to $33 from $36, citing weak Q3 results. The pest control company missed sales and EBITDA expectations, with residential and commercial segments underperforming. Margins were pressured by higher costs. Rollins reported Q3 adjusted earnings of $0.34 per share on revenue of $1.09 billion, both below forecasts. The company lowered its full-year organic growth outlook to 4-6%.

$ROLHigh

Rollins Inc (ROL) Q3 2026 Earnings Call Highlights: Organic Growth Misses as AI Search

Rollins Inc (ROL) reported Q3 2026 organic growth of 4.4%, missing expectations due to residential customer acquisition pressure. AI-driven search disrupted lead flow, causing gross margin to decrease 90 bps YoY and adjusted EBITDA to fall 0.7% YoY. Full-year organic growth guidance was lowered to 4%-6% from 6%. CEO Jerry Gahlhoff noted some improvement in September but cautioned against sustained trends. The company is adjusting strategies to adapt to the changing search landscape.